Quick access

Full HTML PDF
Views: 2581

Downloads: 150
Share Article:
2022 Volume 13 Issue 1

Prevalence of HDNF due to ABO, Rh (D) and Other Blood Groups among Newborns, Sudan


, , , , ,
Abstract

The determination of the frequency of HDFN found in jaundiced newborns in Sudan was the goal of the analysis. In Omdurman maternity inside a Sudanese hospital, 220 mothers and their babies who had jaundice altogether were received in hospital-Sudan and a prospective cross-sectional hospital-based analysis was carried out them. In addition to ABO and Rhesus blood group typing, indirect antiglobulin test (IAT) and direct coomb's test (DAT) was applied for mothers and their jaundiced newborns, respectively. IgG anti-A and anti-B were checked inside the infant’s plasma to detect any incompatibility of ABO. The infant’s blood samples were taken and it underwent the tests of Hemoglobin, Reticulocyte count, thin blood films, and packed cell volume to check the hemolytic status of the baby. The history of abortion, prophylactic anti-D and blood transfusion was written as well. From the analysis, 57.3% (63/110) was the fetus’s and newborn's frequency of hemolytic disease among the studied subjects. The ones with incompatibility of ABO are 28.6% (18/63), and the ones with incompatibility of Rh (D) are 20.6% (13/63) even while prophylactic anti-D was used, while 50.8% (32/63) as a result from other blood groups antigens. The study concluded that the most common cause of HDFN in the studied population is from the other blood group antigens. The analysis also showed that the happening of Rh (D) HDFN wasn’t erased in spite of the Rh immunoglobulin usage.


How to cite this article
Vancouver
Muddathir ARM, Abdallah EI, Elradi WEO, Elbasheir ME, Abdelgadir RE, Waggiallah HA. Prevalence of HDNF due to ABO, Rh (D) and Other Blood Groups among Newborns, Sudan. J Biochem Technol. 2022;13(1):25-8. https://doi.org/10.51847/qvdQ4XmLif
APA
Muddathir, A. R. M., Abdallah, E. I., Elradi, W. E. O., Elbasheir, M. E., Abdelgadir, R. E., & Waggiallah, H. A. (2022). Prevalence of HDNF due to ABO, Rh (D) and Other Blood Groups among Newborns, Sudan. Journal of Biochemical Technology, 13(1), 25-28. https://doi.org/10.51847/qvdQ4XmLif
INDEXING
SCIRUS, Chemical Abstracts, EBSCOhost databases, Genamics JournalSeek, ABCD Journl Index, Asian Science Citation Index (ASCI) and many other international scientific databases.

JOURNAL OF BIOCHEMICAL TECHNOLOGY
JOURNAL OF BIOCHEMICAL TECHNOLOGY
Journal of Biochemical Technology is a double-blind peer reviewed International Journal published by the Deniz Publication on behalf of the Biochemical Technology Society, a Registered Charity Organization from India

AREA OF INTEREST
AREA OF INTEREST
new advances in enzymatic and protein mechanims; applied molecular genetics and biotechnology; genomics and proteomics; metabolic; medical, environmental, food and agro biotechnology.

FOCUS AND SCOPE
FOCUS AND SCOPE
Journal of Biochemical Technology provides a publication on all aspects of biochemistry, biotechnology & bioinformatics and applications in biology and medicine. Areas of high interest cover new advances in enzymatic and protein mechanisms; applied molecular genetics and biotechnology; computational biology, genomics and proteomics; metabolic & tissue engineering; medical, environmental, Pharmacy and pharmaceutical chemistry, food and agro-biotechnology.

Publish with us


Deniz Publication
Guzelyali Mah. Sahilyolu Cad.Defne Sok. No: 7, 34903 Pendik, Istanbul
Email: [email protected]
Tell: +905344990778

Publishing steps

1.Prepare
your paper
2.Submit
and revise
3.Track
your research
4.Share
and promote
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Keywords include, Biochemical Research: Endo/exocytosis, Trafficking, Membrane Biology, Cell Migration, Cell-Matrix Organelle Biogenesis, Cytoskeleton Proteolysis, Cell Death, Cell Cycle, Cancer, Cell Growth/Death, Differentiation, Drug Targets, Gene Therapy, Models of Disease, Proteomics, Stem Cells, Bioenergetics, Mitochondria, Free Radicals, Redox Signaling, Ion Transport/Channels, Oxidative